Abnormal Typical Pattern of Platelet Function and Thromboxane Generation in Unstable Angina

Summary Platelet aggregation (PA), platelet thromboxane B2 (TXB2) generation and 14C 5-hydroxytryptamine (5HT) release were studied in 13 patients with unstable angina, and compared to 14 patients with stable angina and 16 healthy controls. A typical pattern, distinct in 4 aspects from stable angina patients or controls, was observed in the unstable angina patients. ADP or collagen induced shape change was 3-4 times greater, the extent of epinephrine induced PA was nil or very low, the extent of collagen induced 14C 5HT release was also reduced while collagen induced platelet TXB2 generation was increased in spite of a reduced extent of PA. The extent of ADP or collagen induced PA was also significantly reduced. These results indicate a platelet membrane abnormality occurring presumably during contact of the circulating platelets with a non-occlusive thrombus observed at sites of ruptured plaques in unstable angina patients. Since also the pattern (20-30% overlap with control values) was distinct from that of stable angina patients, it might indicate an active thrombotic process. Plasma β-thromboglobulin (βTG) and TXB2 levels and serum TXB2 generation were also studied in the cardiac patients and controls and in another 10 patients with advanced peripheral occlusive arterial disease (POAD). Plasma βTG and TXB2 levels were slightly elevated in the unstable angina patients and markedly elevated in the POAD patients. Serum TXB2 generation was, however, elevated in the stable angina patients (p <0.002) and more so in the unstable angina patients (p <0.001) compared to controls or to POAD patients. This was presumably mediated through enhanced thrombin generation. These results suggest that the measured plasma βTG variable in the unstable angina patients is not useful in the assessment of in vivo platelet activation. It is presumably reflecting the sum of local enhanced platelet activation (at sites of ruptured plaques) and of reduced function of the “defective” circulating platelets. The ability of the platelets of unstable angina patients to generate large amounts of TXB2 if occurring in vivo might induce an intense coronary vasospasm.

[1]  K. Huber,et al.  Circadian Fluctuations of Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma of Patients with Unstable Coronary Artery Disease and Acute Myocardial Infarction , 1988, Thrombosis and Haemostasis.

[2]  L. Wallentin,et al.  Platelet Reactivity in Unstable Coronary Artery Disease , 1987, Thrombosis and Haemostasis.

[3]  J. Mehta,et al.  Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism. , 1987, Circulation.

[4]  R. Abbate,et al.  Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina. , 1987, Thrombosis research.

[5]  V. Fuster,et al.  Mechanisms of unstable angina. , 1986, The New England journal of medicine.

[6]  L Roy,et al.  Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.

[7]  M. Winniford,et al.  Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. , 1986, Journal of the American College of Cardiology.

[8]  D. T. Shiu,et al.  Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. , 1986, Blood.

[9]  L. Harker.  Bleeding after cardiopulmonary bypass. , 1986, The New England journal of medicine.

[10]  J. Mehta,et al.  Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina. , 1985, The Journal of laboratory and clinical medicine.

[11]  D. Sackett,et al.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.

[12]  E. Falk.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[13]  J. Zahavi,et al.  Enhanced Platelet Release Reaction, Shortened Platelet Survival Time and Increased Platelet Aggregation and Plasma Thromboxane B2 in Chronic Obstructive Arterial Disease , 1985, Thrombosis and Haemostasis.

[14]  N. Solum.  Platelet membrane proteins. , 1985, Seminars in hematology.

[15]  M. Winniford,et al.  Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. , 1984, The American journal of cardiology.

[16]  B. Kaye.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina , 1984 .

[17]  W. Campbell,et al.  Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. , 1984, Circulation.

[18]  G. FitzGerald,et al.  Inhibition of thromboxane biosynthesis in serum: Limitations of the measurement of immunoreactive 6-KETO-PGF1α , 1984 .

[19]  C. Forbes,et al.  Plasma Fibrinopeptide A and Beta-Thromboglobulin in Patients with Chest Pain , 1983, Thrombosis and Haemostasis.

[20]  G. FitzGerald,et al.  Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.

[21]  P. Cannon,et al.  Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease. , 1982, Blood.

[22]  D C Levin,et al.  Significance of the Angiographic Morphology of Localized Coronary Stenoses: Histopathologic Correlations , 1982, Circulation.

[23]  E. Myhre,et al.  SELECTIVE INHIBITION OF THROMBOXANE SYNTHETASE BY DAZOXIBEN INCREASES PROSTACYCLIN PRODUCTION BY LEUCOCYTES IN ANGINA PATIENTS AND HEALTHY VOLUNTEERS , 1982, The Lancet.

[24]  R. Mulcahy,et al.  Unstable angina: natural history and determinants of prognosis. , 1981, The American journal of cardiology.

[25]  M. Parry,et al.  UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. , 1981, Thrombosis research.

[26]  H. Tyler,et al.  ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE , 1981, The Lancet.

[27]  L. Hillis,et al.  Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. , 1981, The New England journal of medicine.

[28]  J. Kollath,et al.  Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. , 1981, Atherosclerosis.

[29]  V. Kakkar,et al.  Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia. , 1981, The American journal of medicine.

[30]  V. Kakkar,et al.  β-Thromboglobulin - a Specific Marker of In-Vivo Platelet Release Reaction , 1980, Thrombosis and Haemostasis.

[31]  V. Kakkar,et al.  Enhanced in vivo platelet "release reaction" in old healthy individuals. , 1980, Thrombosis research.

[32]  C. Patrono,et al.  Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. , 1980, Thrombosis research.

[33]  V. Kakkar,et al.  β‐Thromboglobulin, Platelet Production Time and Platelet Function in Vascular Disease , 1979 .

[34]  A. Marcus.  The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. , 1978, Journal of lipid research.

[35]  P. Majerus,et al.  Inhibition of platelet prostaglandin synthetase by oral aspirin. , 1978, The Journal of clinical investigation.

[36]  M. Hamberg,et al.  Extraction and chromatographic procedures for purification of prostaglandins, thromboxanes, prostacyclin, and their metabolites. , 1978, Advances in prostaglandin and thromboxane research.

[37]  P. Weber,et al.  Radioimmunological and biological measurement of prostaglandins in rabbit urine: decrease of PGE2 excretion at high NaCl intake. , 1977, Prostaglandins.

[38]  R. Canfield,et al.  Measurement of fibrinopeptide A in human blood. , 1974, The Journal of clinical investigation.

[39]  H. Holmsen,et al.  Concepts of the blood platelet release reaction. , 1971, Series haematologica.

[40]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.